TABLE 3.
Number of patients achieving at least a reduction of 30% or 50% in clinical pain after duloxetine and placebo treatment. The numbers in the parentheses represent the percentage of the full cohort
| Duloxetine | Placebo | p‐value | |
|---|---|---|---|
| Based on 30% responder criteria | |||
| BPI Worst pain | 16 (64%) | 11 (44%) | 1.000 |
| BPI Average pain | 17 (68%) | 7 (28%) | 0.640 |
| WOMAC pain | 10 (40%) | 11 (44%) | 0.697 |
| WOMAC total | 11 (44%) | 7 (28%) | 1.000 |
| Based on 50% responder criteria | |||
| BPI Worst pain | 11 (44%) | 6 (24%) | 1.000 |
| BPI Average pain | 12 (48%) | 5 (20%) | 0.645 |
| WOMAC pain | 6 (24%) | 5 (20%) | 0.070 |
| WOMAC total | 8 (32%) | 4 (16%) | 1.000 |
Abbreviations: BPI, Brief Pain Inventory; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.